e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
The prognostic value of cardiopulmonary exercise testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prediction of mortality: what variables should we consider?
M. Puhan (Zurich, Switzerland)
Source:
Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Session:
The prognostic value of cardiopulmonary exercise testing
Session type:
Symposium
Number:
1853
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Puhan (Zurich, Switzerland). Prediction of mortality: what variables should we consider?. Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
PG16 Advanced cardiopulmonary exercise testing
Measurement properties of field walking tests in chronic respiratory diseases
Related content which might interest you:
Predictive factors: can we identify patients who will benefit from a specific treatment?
Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer
Year: 2011
Risks of pneumonectomy: which outcome measure?
Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors
Year: 2003
Assessment and treatment of comorbidity: what efforts pay off?
Source: Annual Congress 2011 - The non-parmacological management of COPD exacerbations
Year: 2011
COPD: An outcome of childhood asthma?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Affecting mortality in COPD: Is the dream becoming a reality?
Source: Annual Congress 2006 - The TORCH survival study. Affecting mortality in COPD: Is the dream becoming a reality?
Year: 2006
Predicting survival in pulmonary hypertension in the United Kingdom: Comparison of prognostic equations
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Predicting the clinical outcome in COPD:Who fares thebest-BODE,DOSE or ADO
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?
Source: Eur Respir J 2005; 25: 587-588
Year: 2005
What are the risk factors for a bad outcome of work-related asthma?
Source: Annual Congress 2011 - New ERS Guidelines: Management of Work-Related Asthma
Year: 2011
Predicting factors for success in a tertiary hospital smoking cessation group: Time to rethink our dogmata?
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010
Predicting the risk of falls in patients with COPD: Does age matter?
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012
Survival analysis can help determine which TLco prediction equations to use for patient data
Source: Annual Congress 2011 - Highlights in lung function 2011
Year: 2011
Late Breaking Abstract - CPAP termination and all-cause mortality: a French nationwide database analysis
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
COPD: more treatments but no cure?
Source: Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
Year: 2011
Late-breaking abstract: Pneumonia hospitalizations and long-term exposure to air pollution: A cohort study
Source: Annual Congress 2011 - Outdoor air pollution studies
Year: 2011
Late Breaking Abstract - Relevance of first wave derived COVID-19 prediction scores, in the UK second wave, for mortality and safe early discharge
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Impact of phenotyping upon treatment choices in childhood
Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes
Year: 2010
Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value?
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept